Modeling the effect of chronic schistosomiasis on childhood development and the potential for catch-up growth with different drug treatment strategies promoted for control of endemic schistosomiasis

American Journal of Tropical Medicine and Hygiene

Volumn 84, Issue 5, 2011, Pages 773-781

  Gurarie, David ^a   Wang, Xiaoxia ^a   Bustinduy, Amaya L ^b   King, Charles H ^c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISCHISTOSOMAL AGENT;

AGE DISTRIBUTION; ARTICLE; CATCH UP GROWTH; CHILD DEVELOPMENT; ENDEMIC DISEASE; GROWTH RETARDATION; HEALTH CARE; HEALTH CARE POLICY; HEALTH PROMOTION; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; LONGITUDINAL STUDY; MALNUTRITION; MORBIDITY; QUANTITATIVE ANALYSIS; REINFECTION; RISK ASSESSMENT; RISK FACTOR; SCHISTOSOMIASIS; SIMULATION; STUNTING;

ANTIPROTOZOAL AGENTS; CHRONIC DISEASE; ENDEMIC DISEASES; HUMANS; MODELS, THEORETICAL; SCHISTOSOMIASIS;

SCHISTOSOMA;

EID: 79958713721     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.10-0642     Document Type: Article

References (81)

1. Chitsulo L, Engels D, Montresor A, Savioli L, 2000. The global status of schistosomiasis and its control. Acta Trop 77: 41-51.
2. Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J, 2006. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6: 411-425. (Pubitemid 43949139)
3. King CH, Mahmoud AA, 1989. Drugs five years later: praziquantel. Ann Intern Med 110: 290-296. (Pubitemid 19062158)
4. Fenwick A, 2006. New initiatives against Africa's worms. Trans R Soc Trop Med Hyg 100: 200-207. (Pubitemid 43091816)
5. Molyneux DH, Hotez PJ, Fenwick A, 2005. "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor. PLoS Med 2: e336.
6. Satayathum SA, Muchiri EM, Ouma JH, Whalen CC, King CH, 2006. Factors affecting infection or reinfection with Schistosoma haematobium in coastal Kenya: survival analysis during a nineyear, school-based treatment program. Am J Trop Med Hyg 75: 83-92. (Pubitemid 351627575)
7. King CH, 2007. Lifting the burden of schistosomiasis-defining elements of infection-associated disease and the benefits of antiparasite treatment. J Infect Dis 196: 653-655. (Pubitemid 47293844)
8. King CH, Sturrock RF, Kariuki HC, Hamburger J, 2006. Transmission control for schistosomiasis - why it matters now. Trends Parasitol 22: 575-582. (Pubitemid 44716725)
9. King CH, 2001. Epidemiology of schistosomiasis: determinants of transmission of infection. Mahmoud AA, ed. Schistosomiasis. London, UK : Imperial College Press, 115-132.
10. Smith JH, Christie JD, 1986. The pathobiology of Schistosoma haematobium infection in humans. Hum Pathol 17: 333-345. (Pubitemid 16018570)
11. Richter J, Correia Dacal AR, Vergetti Siqueira JG, Poggensee G, Mannsmann U, Deelder A, Feldmeier H, 1998. Sonographic prediction of variceal bleeding in patients with liver fibrosis due to Schistosoma mansoni. Trop Med Int Health 3: 728-735. (Pubitemid 28450436)
12. van der Werf MJ, de Vlas SJ, Brooker S, Looman CWN, Nagelkerke NJD, Habbema JDF, Engels D, 2003. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 86: 125-139. (Pubitemid 36561364)
13. Koukounari A, Gabrielli AF, Toure S, Bosque-Oliva E, Zhang Y, Sellin B, Donnelly CA, Fenwick A, Webster JP, 2007. Schistosoma haematobium infection and morbidity before and after largescale administration of praziquantel in Burkina Faso. J Infect Dis 196: 659-669. (Pubitemid 47293846)
14. Olveda RM, 2001. Disease in schistosomiasis japonica. Mahmoud AA, ed. Schistosomiasis. London : Imperial College Press, 361-390.
15. King CH, Dickman K, Tisch DJ, 2005. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365: 1561-1569. (Pubitemid 40615405)
16. Friedman JF, Kanzaria HK, Acosta LP, Langdon GC, Manalo DL, Wu H, Olveda RM, McGarvey ST, Kurtis JD, 2005. Relationship between Schistosoma japonicum and nutritional status among children and young adults in Leyte, the Philippines. Am J Trop Med Hyg 72: 527-533. (Pubitemid 41278819)
17. King CH, Dangerfield-Cha M, 2008. The unacknowledged impact of chronic schistosomiasis. Chronic Illn 4: 65-79. (Pubitemid 351341878)
18. Ezeamama AE, Friedman JF, Acosta LP, Bellinger DC, Langdon GC, Manalo DL, Olveda RM, Kurtis JD, McGarvey ST, 2005. Helminth infection and cognitive impairment among Filipino children. Am J Trop Med Hyg 72: 540-548. (Pubitemid 41278821)
19. Nokes C, McGarvey ST, Shiue L, Wu G, Wu H, Bundy DA, Olds GR, 1999. Evidence for an improvement in cognitive function following treatment of Schistosoma japonicum infection in Chinese primary schoolchildren. Am J Trop Med Hyg 60: 556-565. (Pubitemid 29233110)
20. King CH, 2010. Parasites and poverty: the case of schistosomiasis. Acta Trop 113: 95-104.
21. King CH, Bertino AM, 2008. Asymmetries of poverty: why global burden of disease valuations underestimate the burden of neglected tropical diseases. PLoS Negl Trop Dis 2: e209.
22. WHO, 2006. Preventive Chemotherapy in Human Helminthiasis: Coordinated Use of Anthelminthic Drugs in Control Interventions: A Manual for Health Professionals and Programme Managers. Geneva, Switzerland: World Health Organization.
23. Medley GF, Bundy DAP, 1996. Dynamic modeling of epidemiologic patterns of schistosomiasis morbidity. Am J Trop Med Hyg 55: 149-158. (Pubitemid 26391391)
24. Chan MS, Guyatt HL, Bundy DA, Booth M, Fulford AJ, Medley GF, 1995. The development of an age structured model for schistosomiasis transmission dynamics and control and its validation for Schistosoma mansoni. Epidemiol Infect 115: 325-344.
25. Gurarie D, King CH, 2005. Heterogeneous model of schistosomiasis transmission and long-term control: the combined influence of spatial variation and age-dependent factors on optimal allocation of drug therapy. Parasitology 130: 49-65.
26. Gurarie D, King CH, Wang X, 2010. A new approach to modelling schistosomiasis transmission based on stratified worm burden. Parasitology 137: 1951-1965.
27. Stephenson LS, Latham MC, Kurz KM, Kinoti SN, 1989. Single dose metrifonate or praziquantel treatment in Kenyan children. II. Effects on growth in relation to Schistosoma haematobium and hookworm egg counts. Am J Trop Med Hyg 41: 445-453. (Pubitemid 19259236)
28. Stephenson LS, Latham MC, Kurz KM, Kinoti SN, Oduori ML, Crompton DW, 1985. Relationships of Schistosoma haematobium , hookworm and malarial infections and metrifonate treatment to growth of Kenyan school children. Am J Trop Med Hyg 34: 1109-1118. (Pubitemid 16204448)
29. Parraga IM, Assis AM, Prado MS, Barreto ML, Reis MG, King CH, Blanton RE, 1996. Gender differences in growth of schoolaged children with schistosomiasis and geohelminth infection. Am J Trop Med Hyg 55: 150-156. (Pubitemid 26299198)
30. de Onis M, Garza C, Onyango AW, Borghi E, 2007. Comparison of the WHO child growth standards and the CDC 2000 growth charts. J Nutr 137: 144-148. (Pubitemid 46052873)
31. Olds GR, King CH, Hewlett J, Olveda R, Wu G, Ouma JH, Peters PA, McGarvey S, Koech D, Liu CY, Aligui G, Gachihi G, Kombe Y, Parraga I, Ramirez B, Whalen C, Horton RJ, Reeve P, 1999. Double-blind placebo controlled study of concurrent administration of albendazole and praziquantel in school children with schistosomiasis and geohelminths. J Infect Dis 179: 996-1003. (Pubitemid 29159347)
32. Blanton RE, Salam EA, Ehsan A, King CH, Goddard KA, 2005. Schistosomal hepatic fibrosis and the interferon gamma receptor: a linkage analysis using single-nucleotide polymorphic markers. Eur J Hum Genet 13: 660-668. (Pubitemid 40691408)
33. Dessein AJ, Hillaire D, Elwali NE, Marquet S, Mohamed-Ali Q, Mirghani A, Henri S, Abdelhameed AA, Saeed OK, Magzoub MM, Abel L, 1999. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. Am J Hum Genet 65: 709-721. (Pubitemid 30468715)
34. Koukounari A, Fenwick A, Whawell S, Kabatereine NB, Kazibwe F, Tukahebwa EM, Stothard JR, Donnelly CA, Webster JP, 2006. Morbidity indicators of Schistosoma mansoni : relationship between infection and anemia in Ugandan schoolchildren before and after praziquantel and albendazole chemotherapy. Am J Trop Med Hyg 75: 278-286. (Pubitemid 46941345)
35. Leenstra T, Acosta LP, Langdon GC, Manalo DL, Su L, Olveda RM, McGarvey ST, Kurtis JD, Friedman JF, 2006. Schistosomiasis japonica, anemia, and iron status in children, adolescents, and young adults in Leyte, Philippines. Am J Clin Nutr 83: 371-379. (Pubitemid 44713200)
36. Klumpp RK, Webbe G, 1987. Focal, seasonal and behavioural patterns of infection and transmission of Schistosoma haematobium in a farming village at the Volta Lake, Ghana. J Trop Med Hyg 90: 265-281. (Pubitemid 19009674)
37. Kloos H, Fulford AJ, Butterworth AE, Sturrock RF, Ouma JH, Kariuki HC, Thiongo FW, Dalton PR, Klumpp RK, 1997. Spatial patterns of human water contact and Schistosoma mansoni transmission and infection in four rural areas in Machakos District, Kenya. Soc Sci Med 44: 949-968.
38. Kvalsvig JD, Schutte CH, 1986. The role of human water contact patterns in the transmission of schistosomiasis in an informal settlement near a major industrial area. Ann Trop Med Parasitol 80: 13-26. (Pubitemid 16180510)
39. Hagan P, Blumenthal UJ, Chaudri M, Greenwood BM, Hayes RJ, Hodgson I, Kelly C, Knight M, Simpson AJ, Smithers SR, Wilkins HA, 1987. Resistance to reinfection with Schistosoma haematobium in Gambian children: analysis of their immune responses. Trans R Soc Trop Med Hyg 81: 938-946. (Pubitemid 18016013)
40. Etard JF, Audibert M, Dabo A, 1995. Age-acquired resistance and predisposition to reinfection with Schistosoma haematobium after treatment with praziquantel in Mali. Am J Trop Med Hyg 52: 549-558.
41. Kurtis JD, Friedman JF, Leenstra T, Langdon GC, Wu HW, Manalo DL, Su L, Jiz M, Jarilla B, Pablo AO, McGarvey ST, Olveda RM, Acosta LP, 2006. Pubertal development predicts resistance to infection and reinfection with Schistosoma japonicum . Clin Infect Dis 42: 1692-1698. (Pubitemid 43839432)
42. Naus CW, Kimani G, Ouma JH, Fulford AJ, Webster M, van Dam GJ, Deelder AM, Butterworth AE, Dunne DW, 1999. Development of antibody isotype responses to Schistosoma mansoni in an immunologically naive immigrant population: influence of infection duration, infection intensity, and host age. Infect Immun 67: 3444-3451. (Pubitemid 29291515)
43. Olveda RM, Daniel BL, Ramirez BD, Aligui GD, Acosta LP, Fevidal P, Tiu E, de Veyra F, Peters PA, Romulo R, Domingo E, Wiest PM, Olds GR, 1996. Schistosomiasis japonica in the Philippines: the long-term impact of population-based chemotherapy on infection, transmission, and morbidity. J Infect Dis 174: 163-172. (Pubitemid 26255568)
44. Boersma B, Wit JM, 1997. Catch-up growth. Endocr Rev 18: 646-661. (Pubitemid 27435538)
45. Coutinho HM, Acosta LP, McGarvey ST, Jarilla B, Jiz M, Pablo A, Su L, Manalo DL, Olveda RM, Kurtis JD, Friedman JF, 2006. Nutritional status improves after treatment of Schistosoma japonicum -infected children and adolescents. J Nutr 136: 183-188. (Pubitemid 43156506)
46. Coutinho HM, McGarvey ST, Acosta LP, Manalo DL, Langdon GC, Leenstra T, Kanzaria HK, Solomon J, Wu H, Olveda RM, Kurtis JD, Friedman JF, 2005. Nutritional status and serum cytokine profiles in children, adolescents, and young adults with Schistosoma japonicum -associated hepatic fibrosis, in Leyte, Philippines. J Infect Dis 192: 528-536. (Pubitemid 41023134)
47. Wilson RA, van Dam GJ, Kariuki TM, Farah IO, Deelder AM, Coulson PS, 2006. The detection limits for estimates of infection intensity in schistosomiasis mansoni established by a study in non-human primates. Int J Parasitol 36: 1241-1244. (Pubitemid 44376639)
48. WHO, 2002. Prevention and control of schistosomiasis and soiltransmitted helminthiasis: report of a WHO expert committee. WHO Tech Rep Ser 912: 1-57.
49. Assis AM, Barreto ML, Prado MS, Reis MG, Parraga IM, Blanton RE, 1998. Schistosoma mansoni infection and nutritional status in schoolchildren: a randomized, double-blind trial in northeastern Brazil. Am J Clin Nutr 68: 1247-1253. (Pubitemid 28550956)
50. Kirigia JM, 1997. Economic evaluation in schistosomiasis: using the delphi technique to assess effectiveness. Acta Trop 64: 175-190. (Pubitemid 28001090)
51. Bustinduy AL, King CH, 2009. Parasitic helminths. Fratamico PM, Smith JL, Brogden KA, eds. Post-Infectious Sequelae and Long- Term Consequences of Infectious Diseases. Washington, DC : American Society for Microbiology Press, 291-329.
52. Warren KS, 1982. Selective primary health care: strategies for control of disease in the developing world. I. Schistosomiasis. Rev Infect Dis 4: 715-726.
53. Beasley NM, Tomkins AM, Hall A, Kihamia CM, Lorri W, Nduma B, Issae W, Nokes C, Bundy DA, 1999. The impact of population level deworming on the haemoglobin levels of schoolchildren in Tanga, Tanzania. Trop Med Int Health 4: 744-750.
54. Leenstra T, Coutinho HM, Acosta LP, Langdon GC, Su L, Olveda RM, McGarvey ST, Kurtis JD, Friedman JF, 2006. Schistosoma japonicum reinfection after praziquantel treatment causes anemia associated with inflammation. Infect Immun 74: 6398-6407. (Pubitemid 44657422)
55. Kjetland EF, Ndhlovu PD, Kurewa EN, Midzi N, Gomo E, Mduluza T, Friis H, Gundersen SG, 2008. Prevention of gynecologic contact bleeding and genital sandy patches by childhood anti-schistosomal treatment. Am J Trop Med Hyg 79: 79-83. (Pubitemid 351957207)
56. Ouma JH, King CH, Muchiri EM, Mungai P, Koech DK, Ireri E, Magak P, Kadzo H, 2005. Late benefits 10-18 years after drug therapy for infection with Schistosoma haematobium in Kwale District, Coast Province, Kenya. Am J Trop Med Hyg 73: 359-364. (Pubitemid 41278713)
57. Coutinho HM, Leenstra T, Acosta LP, Olveda RM, McGarvey ST, Friedman JF, Kurtis JD, 2007. Higher serum concentrations of DHEAS predict improved nutritional status in helminthinfected children, adolescents, and young adults in Leyte, the Philippines. J Nutr 137: 433-439. (Pubitemid 46213461)
58. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL, 2002. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 May: 1-190.
59. de Onis M, Habicht JP, 1996. Anthropometric reference data for international use: recommendations from a World Health Organization Expert Committee. Am J Clin Nutr 64: 650-658.
60. WHO, 2006. Assessment of differences in linear growth among populations in the WHO Multicentre Growth Reference Study. Acta Paediatr Suppl 450: 56-65.
61. Woolhouse ME, Watts CH, Chandiwana SK, 1991. Heterogeneities in transmission rates and the epidemiology of schistosome infection. Proc R Soc Lond B Biol Sci 245: 109-114. (Pubitemid 23399893)
62. Kvalsvig JD, 1986. The effects of schistosomiasis haematobium on the activity of school children. J Trop Med Hyg 89: 85-90. (Pubitemid 16007159)
63. Gryseels B, 1989. The relevance of schistosomiasis for public health. Trop Med Parasitol 40: 134-142. (Pubitemid 19179890)
64. Tanner M, 1989. Evaluation of public health impact of schistosomiasis . Trop Med Parasitol 40: 143-148. (Pubitemid 19179891)
65. Warren KS, Mahmoud AA, 1976. Targeted mass treatment: a new approach to the control of schistosomiasis. Trans Assoc Am Physicians 89: 195-204. (Pubitemid 8027924)
66. Mott KE, 2004. Schistosomiasis. Murray CJ, Lopez A, Mathers CD, eds. The Global Epidemiology of Infectious Diseases. Geneva, Switzerland : World Health Organization.
67. de Lima e Costa MF, Leite ML, Rocha RS, de Almeida Magalhaes MH, Katz N, 1988. Anthropometric measures in relation to schistosomiasis mansoni and socioeconomic variables. Int J Epidemiol 17: 880-886.
68. McGarvey ST, Wu G, Zhang S, Wang Y, Peters P, Olds GR, Wiest PM, 1993. Child growth, nutritional status, and schistosomiasis japonica in Jiangxi, People's Republic of China. Am J Trop Med Hyg 48: 547-553. (Pubitemid 23141292)
69. Blas BL, Lipayon IL, Tormis LC, Portillo LA, Hayashi M, Matsuda H, 2006. An attempt to study the economic loss arising from Schistosoma japonicum infection and the benefits derived from treatment. Southeast Asian J Trop Med Public Health 37: 26-32. (Pubitemid 43799606)
70. Strauss J, Thomas D, 1998. Health, nutrition, and economic development . J Econ Lit 36: 766-817. (Pubitemid 128458840)
71. Florencio TT, Ferreira HS, Cavalcante JC, Assuncao ML, Sawaya AL, 2008. Short stature and food habits as determining factors for the low productivity of sugarcane laborers in the State of Alagoas, north-eastern Brazil. Arch Latinoam Nutr 58: 33-39.
72. Coly AN, Milet J, Diallo A, Ndiaye T, Benefice E, Simondon F, Wade S, Simondon KB, 2006. Preschool stunting, adolescent migration, catch-up growth, and adult height in young Senegalese men and women of rural origin. J Nutr 136: 2412-2420. (Pubitemid 44330004)
73. Lwambo NJ, Brooker S, Siza JE, Bundy DA, Guyatt H, 2000. Age patterns in stunting and anaemia in African schoolchildren: a cross-sectional study in Tanzania. Eur J Clin Nutr 54: 36-40. (Pubitemid 30102771)
74. Coutinho HM, Leenstra T, Acosta LP, Su L, Jarilla B, Jiz MA, Langdon GC, Olveda RM, McGarvey ST, Kurtis JD, Friedman JF, 2006. Pro-inflammatory cytokines and C-reactive protein are associated with undernutrition in the context of Schistosoma japonicum infection. Am J Trop Med Hyg 75: 720-726. (Pubitemid 46941283)
75. Golden MH, 1994. Is complete catch-up possible for stunted malnourished children? Eur J Clin Nutr 48 (Suppl 1): S58-70 ; discussion S71.
76. Stothard JR, Gabrielli AF, 2007. Schistosomiasis in African infants and preschool children: to treat or not to treat? Trends Parasitol 23: 83-86.
77. Carabin H, Marshall CM, Joseph L, Riley S, Olveda R, McGarvey ST, 2005. Estimating the intensity of infection with Schistosoma japonicum in villagers of Leyte, Philippines. Part I: a Bayesian cumulative logit model. The Schistosomiasis Transmission & Ecology Project (STEP). Am J Trop Med Hyg 72: 745-753.
78. de Vlas SJ, Gryseels B, 1992. Underestimation of Schistosoma mansoni prevalences. Parasitol Today 8: 274-277.
79. Savioli L, Hatz C, Dixon H, Kisumku UM, Mott KE, 1990. Control of morbidity due to Schistosoma haematobium on Pemba Island: egg excretion and hematuria as indicators of infection. Am J Trop Med Hyg 43: 289-295. (Pubitemid 20348456)
80. Shane HL, Verani JR, Abudho B, Montgomery SP, Blackstock AJ, Mwinzi PN, Butler SE, Karanja DM, Secor WE, 2011. Evaluation of urine CCA assays for detection of Schistosoma mansoni infection in western Kenya. PLoS Negl Trop Dis 5: e591.
81. Stothard JR, Sousa-Figuereido JC, Betson M, Adriko M, Arinaitwe M, Rowell C, Besiyge F, Kabatereine NB, 2011. Schistosoma mansoni infections in young children: when are schistosome antigens in urine, eggs in stool and antibodies to eggs first detectable? PLoS Negl Trop Dis 5: e938.